Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;17(1):1-13.
doi: 10.1007/s00792-012-0493-5. Epub 2012 Nov 6.

Systematic and biotechnological aspects of halophilic and halotolerant actinomycetes

Affiliations

Systematic and biotechnological aspects of halophilic and halotolerant actinomycetes

Javad Hamedi et al. Extremophiles. 2013 Jan.

Abstract

More than 70 species of halotolerant and halophilic actinomycetes belonging to at least 24 genera have been validly described. Halophilic actinomycetes are a less explored source of actinomycetes for discovery of novel bioactive secondary metabolites. Degradation of aliphatic and aromatic organic compounds, detoxification of pollutants, production of new enzymes and other metabolites such as antibiotics, compatible solutes and polymers are other potential industrial applications of halophilic and halotolerant actinomycetes. Especially new bioactive secondary metabolites that are derived from only a small fraction of the investigated halophilic actinomycetes, mainly from marine habitats, have revealed the huge capacity of this physiological group in production of new bioactive chemical entities. Combined high metabolic capacities of actinomycetes and unique features related to extremophilic nature of the halophilic actinomycetes have conferred on them an influential role for future biotechnological applications.

PubMed Disclaimer

References

    1. Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1545-1549 - PubMed
    1. Environ Microbiol. 2005 Jul;7(7):1039-48 - PubMed
    1. Int J Syst Evol Microbiol. 2009 Mar;59(Pt 3):555-8 - PubMed
    1. J Antibiot (Tokyo). 2004 Apr;57(4):271-9 - PubMed
    1. Antonie Van Leeuwenhoek. 2005 Jan;87(1):11-8 - PubMed

MeSH terms

LinkOut - more resources